Roche Continues To Make The Case For Gantenerumab In Alzheimer’s Disease

 
• By Mandy Jackson
  
Memory loss due to dementia. Senior woman losing parts of head feeling confused as symbol of decreased mind function. - Image
Gantenerumab decreases amyloid, but will it slow cognitive decline? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D